Contact Us for Best Anaplastic Carcinoma Treatment Doctors in India

Best Anaplastic Carcinoma Treatment Doctors in India

Anaplastic Carcinoma is a rare and highly aggressive form of cancer that can arise in organs such as the thyroid, lung, pancreas, or other tissues. Known for its rapid progression, it requires expert multidisciplinary management combining surgery, targeted therapy, chemotherapy, and radiation. The Best Anaplastic Carcinoma Treatment Doctors in India are internationally trained oncologists, surgeons, and radiation specialists who have extensive experience in treating complex and advanced-stage cancers. With a focus on precision medicine and supportive care, they provide personalized treatment plans that improve survival rates and quality of life.

Here are some of the Best Anaplastic Carcinoma Treatment Doctors in India, recognized worldwide for their excellence in managing Anaplastic Carcinoma with compassion and expertise.

All Cities
  • New Delhi
  • Mumbai
  • Kolkata
oncology
  • IVF and Infertility
  • Cardiology
  • Cosmetic and Plastic Surgery
  • Orthopedic
  • Dental
  • Dermatology
  • Endocrinology
  • ENT
  • Gastroenterology
  • Gynecology and Obstetrics
  • Hematology
  • Hepatology
  • Nephrology
  • Neurology
  • Obesity and Bariatric Surgery
  • Oncology
  • Opthalmology
  • Pulmonology
  • Rheumatology
  • Urology
  • General Surgery
  • Transplant Surgery
  • Vascular Surgery
  • Pediatrics
  • Internal Medicine
  • Spine Surgery
  • Radiology
Procedure
  • Minimally Invasive Cancer Surgery
  • Microsurgical Tumor Removal
  • Cardiac Tumor Treatment
  • Mohs Surgery
  • Fine Needle Aspiration
  • Adrenal Cancer Treatment
  • Bile Duct Cancer Treatment
  • CAR T-Cell Therapy
  • Lumpectomy
  • Carcinoid Tumor Treatment
  • Castleman Disease Treatment
  • Colon Cancer Surgery
  • Completion Thyroidectomy
  • CyberKnife Surgery
  • Free Flap Surgery for Treating Osteoradionecrosis
  • Endometrial Cancer Treatment
  • Actinium-225 (Ac-225) PSMA Therapy
  • Endoscopic Tumor Removal
  • Endometrial Biopsy
  • Radium-223 Dichloride (Xofigo)
  • Benign and Cancerous Tumor Excision
  • I-131 MIBG Therapy
  • Genitourinary Cancer Treatment
  • Lu-177 PSMA Therapy
  • Gestational Trophoblastic Disease (GTD) Treatment
  • Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
  • Image-Guided Radiation Therapy (IGRT)
  • Intensity-Modulated Radiation Therapy (IMRT)
  • Kaposi Sarcoma Treatment
  • Malignant Mesothelioma Treatment
  • Metastatic Tumor Treatment
  • Nasal Cavity and Paranasal Sinus Cancer Treatment
  • Nasopharyngeal Cancer Treatment
  • Non-Small Cell Lung Cancer (NSCLC) Treatment
  • Papillary Thyroid Cancer Treatment
  • Bone Marrow Transplant
  • Brain Tumor Surgery
  • Penile Cancer Treatment
  • Ovarian Biopsy
  • Proton Therapy
  • Radioisotope Therapy
  • Rhabdomyosarcoma (RMS) Treatment
  • Robotic Cancer Surgery
  • Skin Lymphoma Treatment
  • Small Intestine Cancer Treatment
  • Targeted Therapy
  • Thymectomy
  • Thymoma and Thymic Carcinoma Treatment
  • Transarterial Chemoembolization (TACE)
  • Vaginal Cancer Treatment
  • Vulvar Cancer Treatment
  • Whipple Procedure
  • Ewing Family of Tumors Treatment
  • Chemotherapy
  • Hormone Therapy
  • Radiation Therapy
  • Immunotherapy
  • Gamma Knife Radio-Surgery
  • Bacillus Calmette Guerin (BCG) Therapy
  • High-Intensity Focused Ultrasound (HIFU) for Prostate Cancer
anaplastic-carcinoma
  • Pigmented Villonodular Synovitis (PVNS)
  • Adnexal Tumor
  • Mediastinal Teratoma
  • Sacrococcygeal Teratoma (SCT)
  • Nasal Cancer
  • Paranasal Tumor
  • Acute Lymphoblastic Leukemia (ALL)
  • Diffuse Large B-Cell Lymphoma (DLBCL)
  • Acute Myeloid Leukemia (AML)
  • Acute Promyelocytic Leukemia (APL)
  • Adenocarcinoma
  • Adenosquamous Carcinoma
  • Adrenocortical Carcinoma
  • AIDS-Related Cancers
  • Bile Duct Cancer
  • Ameloblastoma
  • Cancer
  • Anal Cancer
  • Carcinomas
  • Anaplastic Carcinoma
  • Colon Cancer
  • Appendix Cancer
  • Cutaneous T-Cell Lymphoma - Lymphoma
  • Atypical Spindle Cell Tumor
  • Ductal Carcinoma
  • Atypical Teratoid/Rhabdoid Tumor (ATRT)
  • Fibrous Histiocytoma of Bone (Malignant) and Osteosarcoma
  • Basal Cell Carcinoma of the Skin
  • Blood Cancer
  • Malignant Fibrous Histiocytoma of Bone and Osteosarcoma
  • Bone Marrow Cancer
  • Bronchial Tumors
  • Midline Tract Carcinoma With NUT Gene Changes
  • Burkitt Lymphoma
  • Cancer in Children
  • Carcinoid Tumor (Gastrointestinal)
  • Cholangio Carcinoma
  • Pediatric Chordomas
  • Chronic Lymphocytic Leukemia (CLL)
  • Chronic Myelogenous Leukemia
  • Chronic Myeloid Leukemia (CML)
  • Chronic Myeloproliferative Neoplasms
  • Desmoid Tumor
  • Pediatric Ependymoma
  • Esthesioneuroblastoma
  • Ewing Sarcoma
  • Extracranial Germ Cell Tumor
  • Extragonadal Germ Cell Tumor
  • Hodgkin Lymphoma
  • Eye Cancer
  • Malignant Fibrous Histiocytoma (MFH)
  • Follicular Lymphoma
  • Gallbladder Cancer
  • Gastric (Stomach) Cancer
  • Pediatric Spinal Tumor
  • Gastrointestinal Stromal Tumor (GIST)
  • Myeloproliferative Neoplasms (MPN)
  • Pediatric Germ Cell Tumor
  • Gestational Trophoblastic Disease
  • Gum Tumor
  • Polycythemia Vera
  • Hairy Cell Leukemia (HCL)
  • Hepatocellular (Liver) Cancer
  • Invasive Breast Cancer
  • Invasive Lobular Carcinoma
  • Islet Cell Tumor
  • Kaposi Sarcoma
  • Renal Cell Cancer
  • Large Cell Carcinoma
  • Large Granular Lymphocytic (LGL) leukemia
  • Laryngeal Cancer
  • Lip and Oral Cavity Cancer
  • Lymphatic Cancer
  • Male Breast Cancer
  • Malignant Mesothelioma
  • Medullary Carcinoma
  • Medulloblastoma
  • Merkel Cell Carcinoma
  • Metastatic Squamous Neck Cancer with Occult Primary
  • Anaplastic Astrocytoma
  • NUT Midline Carcinoma
  • Mouth Cancer
  • Multiple Endocrine Neoplasia (MEN) Syndromes
  • Nasopharyngeal Cancer
  • Neuroendocrine Tumor
  • Non-Hodgkin Lymphoma
  • Non-Small Cell Lung Cancer
  • Oncogenic Osteomalacia
  • Brain Stem Glioma
  • Ovarian Primary Peritoneal Cancer
  • Pancreatic Neuroendocrine Tumor
  • Paraganglioma
  • Parathyroid Cancer
  • Parotid Gland Tumor
  • Pediatric Rhabdomyosarcoma
  • Pediatric Spinal Cord Tumor
  • Pediatric Vascular Tumors
  • Pharyngeal Cancer
  • Pheochromocytoma
  • Pineal Region Tumor
  • Plasma Cell Neoplasms
  • Pleural Tumor
  • Pleuropulmonary Blastoma
  • Primary Central Nervous System (CNS) Lymphoma
  • Rectal Cancer
  • Relapsed ALL
  • Relapsed AML
  • Relapsed Multiple Myeloma
  • Retroperitoneal Tumor
  • Olfactory Neuroblastoma
  • Sezary Syndrome
  • Skull Base Tumor
  • Small Cell Carcinoma
  • Small Intestine Cancer
  • Giant Cell Tumor
  • Soft Tissue Sarcoma
  • Spinal Tumor
  • Synovial Sarcoma
  • Hemangiopericytoma
  • Throat Cancer
  • Thymoma and Thymic Carcinoma
  • Thymus Gland Tumor
  • Tracheobronchial Tumor
  • Transitional Cell Cancer
  • Urethral Cancer
  • Vascular Tumor
  • Waldenstrom Macroglobulinemia
  • Wilms Tumor
  • Malignant Peripheral Nerve Sheath Tumor (MPNST)
  • Nasopharyngeal Angiofibroma
  • Optic Nerve Glioma
  • Acute Lymphocytic Leukemia
  • Adult Hodgkins Lymphoma
  • Bacillus Calmette Guerin (BCG) Treatment for Non-Muscle Invasive Bladder Cancer
  • Astrocytoma
  • Atypical Hyperplasia
  • Basal Cell Carcinoma (BCC)
  • Benign Bone Tumors
  • Benign Lung Tumors
  • Benign Soft Tissue Tumors
  • Bile Duct Cancer, Stones, & Strictures
  • Bone Cancer
  • Breast Cancer
  • Esophagectomy
  • Carcinoid Syndrome
  • Carcinoid Tumors of the Lungs
  • Cervical Cancer
  • Intensity Modulated Radiation Therapy IMRT
  • Childhood Acute Lymphoblastic Leukemia
  • Chordomas
  • Chronic Lymphocytic Leukemia
  • Colorectal Cancer
  • Cutaneous T-Cell Lymphoma
  • Cyclic Neutropenia
  • Ductal Carcinoma in Situ (DCIS)
  • Eosinophilia
  • Estrogen Dependent Cancers
  • Extrahepatic Bile Duct Cancer
  • Ophthalmic Cancer
  • Fallopian Tube Cancer
  • Familial Adenomatous Polyposis (FAP)
  • Familial Adenomatous Polyposis (FAP): Inherited
  • Fanconi Anemia (FA)
  • Gliomas Tumors
  • Head and Neck Cancer
  • Hereditary Non-polyposis Colorectal Cancer (HNPCC)
  • Hurthle Cell Carcinoma
  • Hypopharyngeal Cancer
  • Inflammatory Breast Cancer
  • Intraocular Melanoma
  • Kidney Cancer
  • Leukemia
  • Liver Cancer
  • Liver Cysts & Liver Tumors
  • Lung Cancer
  • Lymphocytosis
  • Malignant Soft Tissue Tumors
  • Mediastinal Tumor
  • Melanoma
  • Meningioma
  • Metastatic Cancer
  • Metastatic Spinal Tumors
  • Metastatic Tumors
  • Multiple Myeloma
  • Oral Cancer
  • Oropharyngeal Cancer
  • Osteosarcoma
  • Ovarian Cancer
  • Ovarian Germ Cell Tumors
  • Pancreatic Cancer
  • Paraneoplastic Syndromes
  • Penile Cancer
  • Prostate Cancer
  • PTEN Hamartoma Tumor Syndrome (Cowden Syndrome and Bannayan-Riley-Ruvalcaba Syndrome)
  • Pulmonary Nodules
  • Pure Red Cell Aplasia (PRCA)
  • Retinoblastoma (Cancer of the Eye)
  • Rhabdomyosarcoma
  • Salivary Gland Cancer
  • Sarcoma
  • Sickle Cell Anemia
  • Skin Cancer
  • Small Cell Lung Cancer
  • Squamous Cell Carcinoma (SCC)
  • Stomach Cancer
  • Sun Exposure & Skin Cancer
  • Testicular Cancer
  • Thrombocytosis
  • Thyroid Cancer
  • Uterine Cancer
  • Uterine Sarcoma
  • Vaginal Cancer
  • Vulvar Cancer
  • Myelofibrosis
  • Brain Cancer (Brain Tumor)
  • Glioblastoma Tumors
  • Schwannomas
  • Bladder Cancer

Dr. Vinod Raina

MBBS, MD, MRCP, FRCP

50 Years of Experience

Medical Oncologist

Fortis Memorial Research Institute (FMRI) Gurugram

Dr. R RANGA RAO

MBBS, DNB, DM

40 Years of Experience

Medical Oncologist

Paras Hospitals, Gurugram

Dr. Priya Tiwari

MBBS, MD, DM

15 Years Years of Experience

Medical Oncologist

Artemis Hospital, Gurgaon

Dr. Ankur Bahl

MBBS, MD, DM, Certificates/Trainings

22 Years of Experience

Medical Oncologist

Fortis Memorial Research Institute (FMRI) Gurugram

Contact Us for Best Anaplastic Carcinoma Treatment Doctors in India

Dr. Imran Khan

MBBS, MD, DNB

12 Years Years of Experience

Medical Oncologist

Fortis Escorts Heart Institute, New Delhi

Dr. Dhruv Dinesh Jain

MBBS, MD, FRCR, Fellowship

7 years Years of Experience

Radiation Oncologist

BLK-Max Super Speciality Hospital, New Delhi

Dr. Kushal Bairoliya

MBBS, MS, MCh, MRCS

13 Years Years of Experience

GI Onco Surgeon, Surgical Oncologist

Fortis Escorts Heart Institute, New Delhi

Dr. Piyusha Kulshrestha

MBBS, MD, Diploma

22ind Years of Experience

Radiation Oncologist

Metro Heart Institute with Multispeciality, Faridabad

Contact Us for Best Anaplastic Carcinoma Treatment Doctors in India

Who are the Best Anaplastic Carcinoma Treatment Doctors in India?

India’s best anaplastic carcinoma doctors are typically multidisciplinary teams made up of:

  • Endocrine and head-and-neck surgeons with experience in complex resections and airway management.
  • Radiation oncologists proficient in modern techniques such as intensity-modulated radiotherapy (IMRT) and image-guided radiotherapy (IGRT).
  • Medical oncologists experienced in cytotoxic chemotherapy, targeted therapy and immunotherapy for rare aggressive tumors.
  • Palliative care and supportive medicine specialists who manage symptoms and quality of life.

These doctors often train internationally, publish in peer-reviewed journals, and participate in global clinical trials. Many centres offer tumor boards where specialists review each case and develop individualized plans. Evidence shows that multidisciplinary care—combining surgery, radiotherapy and systemic therapy—improves local control and can extend survival in select patients.

What Is Anaplastic Carcinoma?

Anaplastic carcinoma most commonly refers to anaplastic thyroid carcinoma (ATC)—a rare, undifferentiated, and highly aggressive cancer of the thyroid gland. It grows rapidly, invades adjacent neck structures, and frequently metastasizes early. ATC accounts for a small fraction of thyroid cancers but represents a disproportionate share of thyroid-cancer mortality. Typical presentation includes a rapidly enlarging neck mass often associated with pain, hoarseness, difficulty swallowing or breathing.

Briefly:

  • It is undifferentiated—tumor cells no longer resemble normal thyroid cells.
  • It commonly presents in older adults and may arise from long-standing differentiated thyroid cancer.

How Do India’s Top Doctors Diagnose and Treat Anaplastic Carcinoma?

Diagnosis and staging are fast and comprehensive because ATC can cause airway compromise and rapid deterioration.

First steps in diagnosis (brief):

  • Clinical examination focusing on airway, swallowing and vocal cord function.
  • High-resolution ultrasound of the neck and cross-sectional imaging (contrast CT or MRI) to assess local invasion.
  • PET-CT when distant metastasis is suspected.
  • Core biopsy or fine needle aspiration with immunohistochemistry and molecular testing (BRAF, TP53, etc.) to guide targeted therapy options.

Treatment approach: multidisciplinary and individualized. Common strategies include:

  • Emergency airway management when there is impending obstruction (tracheostomy or stenting).
  • Surgery for resectable locoregional disease—aiming for maximal safe debulking while preserving function.
  • Definitive radiotherapy (frequently combined with radiosensitizing chemotherapy) to control locoregional disease. Modern fractionation and IMRT techniques are commonly used.
  • Systemic therapy: chemotherapy, targeted agents (for specific mutations such as BRAF V600E), and increasingly immunotherapy. Combinations (chemo-radiation or chemo-immunotherapy) are often used for improved control.

What Are the Available Treatment Options for Anaplastic Carcinoma in India?

India offers the full spectrum of treatment modalities commonly used worldwide:

  • Surgery (open, en-bloc resections, airway procedures): best when disease is localized and resectable. Surgery can be curative only in a minority of patients but is crucial when airway or swallowing is threatened.
  • Radiation therapy (IMRT/VMAT/IGRT): frequently delivered in 25–46 fractions depending on intent. For ATC, hypofractionated or accelerated regimens may be used in conjunction with chemotherapy. Modern techniques markedly reduce radiation to adjacent structures.
  • Chemotherapy: used as induction, concurrent (with radiotherapy), or palliative systemic therapy. Common agents include doxorubicin, paclitaxel, carboplatin and combinations tailored by the medical oncologist.
  • Targeted therapy: for molecularly defined tumors (e.g., BRAF-mutant tumors using BRAF/MEK inhibitors). Molecular profiling is increasingly standard in ATC management.
  • Immunotherapy: immune checkpoint inhibitors (PD-1/PD-L1) are used in select cases and in clinical trials; combined chemo-immunotherapy has shown promising responses in some recent reports.
  • Palliative care and symptom management: essential for quality of life, airway protection, pain control, nutrition support and psychosocial care.

Advantages of each method (brief paragraph then bullets):
Surgery can relieve compression and debulk tumor burden; radiation provides local control; systemic therapies can treat microscopic and distant disease and, when targeted, may produce dramatic responses in molecularly defined tumors.

  • Surgery: immediate reduction of mass effect; potential survival benefit in carefully selected patients.
  • Radiation: precise local control with modern techniques; radiosensitization when combined with chemotherapy.
  • Chemotherapy/Targeted/Immunotherapy: systemic disease control; targeted agents can offer significant responses when mutations are present.
  • Palliative/supportive care: improves comfort and overall treatment tolerance.

What Are the Types of Devices Used?

Treatment uses several advanced devices and systems common in modern oncology centres:

  • Linear accelerators supporting IMRT/VMAT and IGRT for precise radiation delivery.
  • PET-CT and contrast CT/MRI scanners for staging and planning.
  • Stereotactic systems for precise high-dose delivery when appropriate.
  • Advanced operative tools for head-and-neck microsurgery and airway management.
  • Laboratory platforms for molecular profiling (next-generation sequencing).

What Is the Cause of Anaplastic Carcinoma?

The precise cause is not fully understood. ATC often arises from dedifferentiation of pre-existing differentiated thyroid cancer (papillary or follicular). Risk factors include older age, long-standing goiter and prior radiation exposure to the neck. Genetic mutations (e.g., TP53, BRAF) are commonly implicated.

What Are the Symptoms of Anaplastic Carcinoma?

Symptoms reflect rapid tumor growth and local invasion: a rapidly enlarging neck mass, voice changes, dysphagia, breathing difficulty, neck pain, and sometimes cough or hemoptysis. Because progression can be swift, urgent evaluation is indicated for any rapidly growing neck lesion.

What Are the Complications of Anaplastic Carcinoma?

Complications arise from local invasion and systemic spread: airway obstruction, recurrent laryngeal nerve palsy, esophageal involvement, hemorrhage, distant metastases (lungs, bone, brain), and treatment-related toxicities (radiation mucositis, chemotherapy side effects). Palliative needs are often urgent.

How Is Anaplastic Carcinoma Diagnosed?

Diagnosis uses a combination of clinical assessment and targeted investigations:

  • High-resolution neck ultrasound and contrast CT/MRI for local staging.
  • PET-CT when distant disease is suspected.
  • Core biopsy or FNA with immunohistochemistry and molecular analysis to confirm undifferentiated histology and identify actionable mutations.

What Is the Treatment for Anaplastic Carcinoma?

Treatment is individualized but usually multimodal. For operable, localized disease the recommended approach often involves maximal safe surgery followed by adjuvant radiotherapy and systemic therapy. For unresectable or metastatic disease, combined radiotherapy with systemic agents (chemotherapy, targeted therapy, immunotherapy) aims to control symptoms and prolong survival. Palliative care is integrated from diagnosis to manage symptoms, nutrition and airway protection.

Why Choose India for Anaplastic Carcinoma Treatment?

India has become a preferred destination for international cancer care because of:

  • Highly skilled specialists with international training in complex head-and-neck and endocrine oncology.
  • Advanced technology: modern linear accelerators, IMRT/VMAT, PET-CT, molecular labs.
  • Multidisciplinary tumor boards that create rapid, individualized plans.
  • Accredited hospitals (JCI/NABH) with international patient services.
  • Affordability: treatment costs in India often represent substantial savings compared to the USA, UK and Singapore while maintaining high quality standards.

What Are the Success Rates of Anaplastic Carcinoma in India?

Overall survival for ATC remains limited worldwide because of its aggressive biology. Historically, median survival is measured in months, and 5-year survival is rare. However, outcomes can improve in selected patients receiving aggressive multimodal therapy (surgery + radiotherapy + systemic therapy), and when targeted or immunotherapies are effective for molecularly defined tumors. Reported improvements in local control and some survival benefit have followed modern combined approaches.

What Is the Cost of Anaplastic Carcinoma Treatment in India?

Below is an indicative cost table for common procedures and therapies in India (USD). Actual costs vary with hospital, city, patient status and specific treatment plan.

Type of Procedure / Service

Estimated Cost (USD)

Initial Evaluation & Staging (imaging, biopsy, labs)

$800 – $2,500

Surgery (complex head & neck resection ± reconstruction)

$3,500 – $12,000

Radiation therapy (30 fractions, IMRT/VMAT)

$4,000 – $6,000 (typical range for 30 fractions).

Chemotherapy (per cycle; standard agents)

$700 – $1,500 per cycle (varies by agent). (user-specified range aligns with Indian pricing.)

Targeted therapy (per course; molecularly defined drugs)

$1,200 – $8,000+ depending on drug and duration.

Immunotherapy (per cycle)

$2,200 – $5,000+ per cycle (approximate range; depends on agent). (user noted similar ranges for analogous treatments).

Hospital stay (per day)

$150 – $800 depending on facility and room category.

Palliative / supportive care packages

$500 – $3,000 depending on services.

Notes: These cost ranges reflect broad industry estimates and published Indian cost guides. Precise quotes require case review and hospital estimates.

How Long Is the Recovery Process?

Recovery timelines depend on the chosen interventions:

  • After surgery: hospital stay often 5–14 days for major resections with reconstruction; return to baseline function may take weeks to months, with voice and swallowing rehabilitation as needed.
  • During/after radiotherapy: acute effects (mucositis, skin changes, fatigue) typically peak during treatment and improve over 4–12 weeks; long-term effects may require rehabilitation.
  • Systemic therapy: chemotherapy/immunotherapy side effects vary; many patients continue therapy in outpatient settings with periodic monitoring.

Total time in India for an international patient typically includes evaluation (1–2 weeks), active treatment (variable—surgery plus 4–6 weeks radiotherapy or systemic cycles) and immediate recovery/follow-up (additional 2–6 weeks). Your HealZone coordinator will tailor the plan and estimate duration based on the chosen protocol.

What Post-Treatment and Follow-Up Care Are Provided?

Indian cancer centres provide comprehensive post-treatment services including:

  • Scheduled outpatient oncologist follow-ups and imaging.
  • Rehabilitation: speech and swallow therapy, physiotherapy, nutritional support.
  • Telemedicine consultations for remote follow-up and symptom management.
  • Psycho-social support and palliative care integration when needed.

How HealZone Supports International Patients with Anaplastic Carcinoma?

HealZone (the medical tourism platform) provides end-to-end support for international patients:

  • Doctor & hospital selection: streamlined shortlists of accredited specialists and centres with ATC expertise.
  • Cost estimates & transparency: itemized quotes for surgery, radiotherapy (including IMRT 30 fractions), chemotherapy cycles and supportive services.
  • Travel & visa assistance: guidance on medical visas and local logistics.
  • Accommodation & local support: hospital-adjacent lodging, interpreter services, airport pick-up.
  • Clinical coordination & fast-track scheduling: ensuring rapid diagnostic workup and multidisciplinary review.
  • Postoperative care & tele-follow-up: secure teleconsultations and coordination with local physicians for long-term care.

HealZone’s role is to reduce barriers for international patients seeking high-quality, affordable care in India while maintaining transparency and continuity.